CB 003

Drug Profile

CB 003

Alternative Names: CB-003; GC enriched liposomal vinorelbine - Ceronco Biosciences; Glucosylceramide enriched liposomal vinorelbine - Ceronco Biosciences; Vinorelbine liposomal - Ceronco Biosciences

Latest Information Update: 27 Oct 2016

Price : $50

At a glance

  • Originator Ceronco Biosciences
  • Class Antineoplastics; Small molecules; Vinca alkaloids
  • Mechanism of Action Mitosis inhibitors; Tubulin polymerisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Cancer

Most Recent Events

  • 26 Oct 2016 Preclinical trials in Cancer in Netherlands (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top